Rayburn West Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$720K Hold
600
0.4% 48
2026
Q1
$552K Sell
600
-12
-2% -$12.2K 0.33% 50
2025
Q4
$658K Buy
+612
New +$585K 0.41% 48

Other funds holding LLY

Rayburn West Financial Services's LLY Position: Q2 2026 in Review

Rayburn West Financial Services held its Eli Lilly (LLY) position steady in Q2 2026 at 600 shares worth $720K. The position accounts for 0.4% of the portfolio, ranked #48.

Rayburn West Financial Services first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rayburn West Financial Services held 600 shares of Eli Lilly worth $720K as of Q2 2026.
  • Rayburn West Financial Services left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.4% of Rayburn West Financial Services's portfolio in Q2 2026, its #48 holding.
  • Rayburn West Financial Services first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rayburn West Financial Services's 13F filing for Q2 2026, filed 7 Aug 2026.